Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma

Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma

Abstract Background Molecular markers predicting survival in esophageal adenocarcinoma (EAC) are rare. Specifically, in favorable oncologic situations, e.g. nodal negativity or major neoadjuvant therapy response, there is a lack of additional risk factors that serve to predict patients’ outcome more...

Full description

Bibliographic Details
Main Authors: Lars M. Schiffmann, Heike Göbel, Heike Löser, Fabian Schorn, Jan Paul Werthenbach, Hans F. Fuchs, Patrick S. Plum, Marc Bludau, Thomas Zander, Wolfgang Schröder, Christiane J. Bruns, Hamid Kashkar, Alexander Quaas, Florian Gebauer
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Cancer
Subjects:
XIAP
EAC
Biomarker of response
Outcome prediction
Online Access:http://link.springer.com/article/10.1186/s12885-019-5722-1

Internet

http://link.springer.com/article/10.1186/s12885-019-5722-1

Similar Items